On January 2, 2020 Bio-Techne Corporation (NASDAQ:TECH) reported that Chuck Kummeth, President and Chief Executive Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at 3:00 p.m. PST (Press release, Bio-Techne, JAN 2, 2020, View Sourcenews/detail/169/bio-techne-to-present-at-the-38th-annual-j-p-morgan-healthcare-conference" target="_blank" title="View Sourcenews/detail/169/bio-techne-to-present-at-the-38th-annual-j-p-morgan-healthcare-conference" rel="nofollow">View Source [SID1234552648]). The conference will be held at the Westin St. Francis Hotel in San Francisco, CA. A live webcast of the presentation can be accessed via Bio-Techne’s Investor Relations website at View Source or through the following link View Source

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On January 2, 2020 Boston Scientific Corporation (NYSE: BSX) reported that it will participate in the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 in San Francisco, California (Press release, Boston Scientific, JAN 2, 2020, View Source [SID1234552669]). Mike Mahoney, chairman and chief executive officer, will present at approximately 8:00 a.m. PST / 11:00 a.m. EST. At 8:30 a.m. PST / 11:30 a.m. EST, Mahoney will be joined by Dan Brennan, executive vice president and chief financial officer, Ian Meredith, MD, executive vice president and global chief medical officer, and Susie Lisa, vice president, Investor Relations, in a question-and-answer session with the host analyst and audience members.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On Friday, January 24, 2020 Boston Scientific will host and webcast an investor update at the 2020 North American Neuromodulation Society (NANS 2020), beginning at 7:00 a.m. PST / 10:00 a.m. EST. The event will be hosted by Maulik Nanavaty, senior vice president and president, Neuromodulation and will provide a business update and answer questions from investors about the Boston Scientific Neuromodulation portfolio.

On Wednesday, February 5, 2020 Boston Scientific will webcast its conference call discussing financial results and business highlights for the fourth quarter ended December 31, 2019. The call will begin at 8:00 a.m. EST, hosted by Mike Mahoney and Dan Brennan. The company will issue a news release announcing financial results for the fourth quarter on Wednesday, February 5, 2020, prior to the conference call.

A live webcast and replay of the webcast for each event will be accessible at investors.bostonscientific.comView Source The replay will be available beginning approximately one hour following the completion of each event.

On January 2, 2020 Bristol-Myers Squibb Company (NYSE: BMY) reported will take part in a fireside chat at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference on Thursday, January 9, 2020 in New York (Press release, Bristol-Myers Squibb, JAN 2, 2020, View Source [SID1234552649]). Giovanni Caforio, M.D., chairman and chief executive officer will answer questions at 10:25 a.m. ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors and the general public are invited to listen to a live webcast of the session at View Source Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

On January 2, 2020 Global health service company Cigna (NYSE: CI) reported that David Cordani, President and Chief Executive Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020 in San Francisco, CA (Press release, Cigna , JAN 2, 2020, View Source [SID1234552670]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cigna’s presentation is expected to begin at approximately 10:00 a.m. PST. Investors, analysts, and the general public are invited to listen to the presentation free over the Internet via webcast by visiting View Source and clicking on About Cigna, then Investor Relations, then the Investor Events link.

To listen to this presentation live on the Internet, visit View Source at least 15 minutes prior to the presentation (to download and install any necessary audio software).

On January 2, 2020 Exact Sciences Corp. (Nasdaq: EXAS) reported that company management will participate in the following investor conference and invited investors to participate by webcast (Press release, Exact Sciences, JAN 2, 2020, View Source [SID1234552650]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

J.P. Morgan Healthcare Conference presentation, San Francisco
Wednesday, Jan. 15, 2020, at 3:00 p.m. EST
J.P. Morgan Healthcare Conference question & answer session, San Francisco
Wednesday, Jan. 15, 2020, at 4:30 p.m. EST
The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.